Healthcare -
Biotechnology - NASDAQ - US
$ 43.33
-0.161 %
$ 4 B
Market Cap
-6.82
P/E
RARE - GROSS PROFIT
Gross Profit RARE - Ultragenyx Pharmaceutical Inc.
389 M
LAST VALUE
7.70%
2 YEAR CAGR
50.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR